德林海：8月28日召开董事会会议

Group 1 - The company Delinhai (SH 688069) held its fourth third board meeting on August 28, 2025, to review the proposal for the first grant of restricted stock to incentive objects [1] - For the year 2024, Delinhai's revenue composition shows that the ecological protection and environmental governance sector accounts for 99.63%, while other businesses make up 0.37% [1] - As of the report date, Delinhai's market capitalization is 2.6 billion yuan [1] Group 2 - The news highlights a significant medical advancement with the world's first successful transplantation of gene-edited pig lungs into humans, raising questions about the timeline for clinical applications [1]